Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
28.64
-0.28 (-0.97%)
At close: May 17, 2024, 4:01 PM
28.68
+0.04 (0.14%)
After-hours: May 17, 2024, 7:59 PM EDT
Pfizer Revenue
Pfizer had revenue of $55.09B in the twelve months ending March 31, 2024, down -40.86% year-over-year. Revenue in the quarter ending March 31, 2024 was $14.88B, a -19.51% decrease year-over-year. In the year 2023, Pfizer had annual revenue of $58.50B, a decrease of -41.70%.
Revenue (ttm)
$55.09B
Revenue Growth
-40.86%
P/S Ratio
2.94
Revenue / Employee
$626,068
Employees
88,000
Market Cap
162.15B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
| Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
| Dec 31, 2018 | 40.83B | -11.72B | -22.31% |
| Dec 31, 2017 | 52.55B | -278.00M | -0.53% |
| Dec 31, 2016 | 52.82B | 3.97B | 8.13% |
| Dec 31, 2015 | 48.85B | -754.00M | -1.52% |
| Dec 31, 2014 | 49.61B | -1.98B | -3.84% |
| Dec 31, 2013 | 51.58B | -3.07B | -5.62% |
| Dec 31, 2012 | 54.66B | -6.38B | -10.45% |
| Dec 31, 2011 | 61.04B | -4.13B | -6.34% |
| Dec 31, 2010 | 65.17B | 15.90B | 32.26% |
| Dec 31, 2009 | 49.27B | 973.00M | 2.01% |
| Dec 31, 2008 | 48.30B | -122.00M | -0.25% |
| Dec 31, 2007 | 48.42B | 47.00M | 0.10% |
| Dec 31, 2006 | 48.37B | 966.00M | 2.04% |
| Dec 31, 2005 | 47.41B | -1.58B | -3.23% |
| Dec 31, 2004 | 48.99B | 4.25B | 9.50% |
| Dec 31, 2003 | 44.74B | 12.44B | 38.53% |
| Dec 31, 2002 | 32.29B | 3.27B | 11.27% |
| Dec 31, 2001 | 29.02B | 2.98B | 11.44% |
| Dec 31, 2000 | 26.05B | -1.12B | -4.13% |
| Dec 31, 1999 | 27.17B | 3.94B | 16.94% |
| Dec 31, 1998 | 23.23B | 12.18B | 110.14% |
| Dec 31, 1997 | 11.06B | 1.19B | 12.07% |
| Dec 31, 1996 | 9.86B | -157.00M | -1.57% |
| Dec 31, 1995 | 10.02B | 2.04B | 25.62% |
| Dec 31, 1994 | 7.98B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elevance Health | 171.75B |
| Novartis AG | 49.92B |
| Thermo Fisher | 42.49B |
| Abbott Laboratories | 40.33B |
| Medtronic | 32.32B |
| Amgen | 29.53B |
| Danaher | 22.52B |
| Stryker | 20.96B |
PFE News
- 23 hours ago - Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial - Reuters
- 2 days ago - Pfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reports - Reuters
- 5 days ago - Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting - PRNewsWire
- 5 days ago - Pfizer's next move: Can it break above $30? - Invezz
- 6 days ago - Pfizer and AstraZeneca announce new investments of nearly $1 billion in France - Reuters
- 7 days ago - A Struggling Pfizer Looks for Help From a Wall Streeter - Barrons
- 10 days ago - Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer - New York Post
- 10 days ago - Pfizer agrees to settle more than 10,000 Zantac cancer lawsuits - Bloomberg News - Reuters